The important prognostic information provided by CMR post TAVR
- ARTICLES
- diciembre 16, 2015
s
Listen to your patients. The best way to learn.
LEER MÁSFOURIER is a mega-trial of clinical efficacy and safety of evolocumab added to treatment with moderate / high intensity statins in patients with clinically evident atherosclerotic cardiovascular disease (ASCVD).
LEER MÁSToday is World Heart Day and The Caribbean Cardiac Society joins the World Heart Federation and organisations around the world in encouraging the creation of healthy heart environments wherever people live, work and play.
LEER MÁSSTICHES: Coronary Bypass Surgery in Patients with Left Ventricular Dysfunction
LEER MÁSThe review by Yusuf and colleagues proclaims that ‘there is no convincing evidence that moderate intake of sodium (3-5 g /day*) is associated with increased risk of CVD compared with lower levels of sodium consumption’.
LEER MÁS